Evidence map›Paper›PMID 42283059›Full record

ArticleOrthopaedic journal of sports medicine2026

Defining the Minimal Clinically Important Difference and Patient Acceptable Symptom State for Isolated Microfracture of the Knee at 5-Year Follow-up.

Rodrigo Saad Berreta, Zeeshan A Khan, Sachin Allahabadi, Joshua Wright-Chisem, Jonathan Spaan, Jared Rubin, Juan Bernardo Villarreal-Espinosa, Adam B Yanke, Brian Forsythe, Nikhil N Verma and 2 more

Abstract read
In one paragraph

Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rodrigo Saad BerretaDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-6019-7509
Zeeshan A KhanRush University Medical College, Chicago, Illinois, USA.
Sachin AllahabadiHouston Methodist Hospital, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1185-3039
Joshua Wright-ChisemDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.
Jonathan SpaanRush University Medical College, Chicago, Illinois, USA.
Jared RubinRush University Medical College, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0004-7000-8726
Juan Bernardo Villarreal-EspinosaDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.
Adam B YankeDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.
Brian ForsytheDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-1665-5872
Nikhil N VermaDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.
Jorge ChahlaDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.
Brian J ColeDepartment of Orthopedics, Rush University Medical Center, Chicago, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a paucity of literature regarding the long-term clinical significance and patient-reported outcome measures (PROMs) after isolated microfracture of the knee for cartilage defects. Purposes: To (1) define the minimally clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds for knee microfracture at a minimum 5-year follow-up, and (2) investigate predictive factors-including preoperative, demographic, and intraoperative variables-to achieve MCID and PASS. Study Design: Case-control study; Level of evidence, 3. Methods: All patients who underwent isolated microfracture for knee chondral defects from 2013 to 2018 were retrospectively identified through a prospectively-maintained institutional database. MCID thresholds were determined by a distribution-based method, while PASS thresholds were established using an anchor-based method. The PROMs analyzed included the International Knee Documentation Committee (IKDC) score and the Knee injury and Osteoarthritis Outcome Score (KOOS). Multivariate logistic regression was performed to identify factors associated with achieving the MCID and PASS thresholds. Results: A total of 70 patients were included in the study. The thresholds for MCID achievement and achievement rates were as follows: IKDC, 11.13 (68.57%); KOOS activities of daily living (ADL), 10.56 (65.71%); KOOS Pain, 9.83 (72.86%); KOOS quality of life (QoL), 14.47 (67.14%); KOOS Sport, 14.65 (68.57%); and KOOS Symptoms, 9.95 (58.57%). The thresholds for PASS achievement and achievement rates were as follows: IKDC, 67.24 (58.57%); KOOS ADL, 96.31 (44.29%); KOOS Pain, 85.54 (51.43%); KOOS QoL, 56.38 (55.71%); KOOS Sport, 57.41 (55.71%); and KOOS Symptoms, 76.74 (54.29%). A lower preoperative score was predictive of achieving the MCID for the IKDC and each KOOS subscale. A Kellgren-Lawrence (K-L) grade of 0 or 1 was predictive of achieving the PASS for the IKDC, KOOS Pain, and KOOS Symptoms. A lower body mass index (BMI) was predictive of achieving the PASS for the KOOS ADL and the KOOS Pain, in addition to attaining the MCID for the KOOS ADL, KOOS Pain, and KOOS Sport. A lesion size of <2 cm Conclusion: This study defines the thresholds for MCID and PASS achievement at a minimum 5-year follow-up for patients undergoing isolated microfracture of the knee. Patient-specific and defect-specific factors associated with MCID and PASS achievement included lower BMI, younger age, male sex, lower K-L grade, and smaller lesion sizes.

Indexed as

cartilageclinically significant outcomeskneemicrofractureosteochondritis dissecans

Identifiers

PMID42283059
PMCPMC13250429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.